These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 29288524)

  • 1. Insulin deficiency with and without glucagon: A comparative study between total pancreatectomy and type 1 diabetes.
    Niwano F; Hiromine Y; Noso S; Babaya N; Ito H; Yasutake S; Matsumoto I; Takeyama Y; Kawabata Y; Ikegami H
    J Diabetes Investig; 2018 Sep; 9(5):1084-1090. PubMed ID: 29288524
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glucose turnover and recycling in diabetes secondary to total pancreatectomy: effect of glucagon infusion.
    Vigili de Kreutzenberg S; Maifreni L; Lisato G; Riccio A; Trevisan R; Tiengo A; Del Prato S
    J Clin Endocrinol Metab; 1990 Apr; 70(4):1023-9. PubMed ID: 2180971
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of insulin replacement on intermediary metabolism in diabetes secondary to pancreatectomy.
    Del Prato S; Tiengo A; Baccaglini U; Tremolada C; Duner E; Marescotti MC; Avogaro A; Valverde I; Nosadini R; Assan R
    Diabetologia; 1983 Sep; 25(3):252-9. PubMed ID: 6357912
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential effects of ambient blood glucose level and degree of obesity on basal serum C-peptide level and the C-peptide response to glucose and glucagon in non-insulin-dependent diabetes mellitus.
    Park SW; Ihm SH; Yoo HJ; Park JY; Lee KU
    Diabetes Res Clin Pract; 1997 Sep; 37(3):165-71. PubMed ID: 9306037
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combination therapy of glucagon-like peptide-1 receptor agonists and insulin for patients who developed diabetes after partial pancreatectomy.
    Kitazawa T; Yokoyama K; Kubota K
    J Diabetes Investig; 2016 May; 7(3):381-5. PubMed ID: 27330725
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Total pancreatectomy increases the metabolic response to glucagon in humans.
    Bajorunas DR; Fortner JG; Jaspan J; Sherwin RS
    J Clin Endocrinol Metab; 1986 Aug; 63(2):439-46. PubMed ID: 3522619
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Beta-cell response to intravenous glucagon in African-American and Hispanic children with type 2 diabetes mellitus.
    Taha DR; Castells S; Umpaichitra V; Bastian W; Banerji MA
    J Pediatr Endocrinol Metab; 2002 Jan; 15(1):59-67. PubMed ID: 11822582
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diabetes management in patients undergoing total pancreatectomy: A single center cohort study.
    Zhao T; Fu Y; Zhang T; Guo J; Liao Q; Song S; Duo Y; Gao Y; Yuan T; Zhao W
    Front Endocrinol (Lausanne); 2023; 14():1097139. PubMed ID: 36860372
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impaired glucose-induced glucagon suppression after partial pancreatectomy.
    Schrader H; Menge BA; Breuer TG; Ritter PR; Uhl W; Schmidt WE; Holst JJ; Meier JJ
    J Clin Endocrinol Metab; 2009 Aug; 94(8):2857-63. PubMed ID: 19491219
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glucagon-like peptide 1 increases insulin sensitivity in depancreatized dogs.
    Sandhu H; Wiesenthal SR; MacDonald PE; McCall RH; Tchipashvili V; Rashid S; Satkunarajah M; Irwin DM; Shi ZQ; Brubaker PL; Wheeler MB; Vranic M; Efendic S; Giacca A
    Diabetes; 1999 May; 48(5):1045-53. PubMed ID: 10331409
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The GLP-1 receptor agonist lixisenatide reduces postprandial glucose in patients with diabetes secondary to total pancreatectomy: a randomised, placebo-controlled, double-blinded crossover trial.
    Juel CTB; Lund A; Andersen MM; Hansen CP; Storkholm JH; Rehfeld JF; van Hall G; Hartmann B; Wewer Albrechtsen NJ; Holst JJ; Vilsbøll T; Knop FK
    Diabetologia; 2020 Jul; 63(7):1285-1298. PubMed ID: 32394228
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bedtime administration of NN2211, a long-acting GLP-1 derivative, substantially reduces fasting and postprandial glycemia in type 2 diabetes.
    Juhl CB; Hollingdal M; Sturis J; Jakobsen G; Agersø H; Veldhuis J; Pørksen N; Schmitz O
    Diabetes; 2002 Feb; 51(2):424-9. PubMed ID: 11812750
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of glyburide on glycemic control, insulin requirement, and glucose metabolism in insulin-treated diabetic patients.
    Simonson DC; Delprato S; Castellino P; Groop L; DeFronzo RA
    Diabetes; 1987 Feb; 36(2):136-46. PubMed ID: 3100365
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glucose counterregulation in patients after pancreatectomy. Comparison with other clinical forms of diabetes.
    Polonsky KS; Herold KC; Gilden JL; Bergenstal RM; Fang VS; Moossa AR; Jaspan JB
    Diabetes; 1984 Nov; 33(11):1112-9. PubMed ID: 6389228
    [TBL] [Abstract][Full Text] [Related]  

  • 15. One week's treatment with the long-acting glucagon-like peptide 1 derivative liraglutide (NN2211) markedly improves 24-h glycemia and alpha- and beta-cell function and reduces endogenous glucose release in patients with type 2 diabetes.
    Degn KB; Juhl CB; Sturis J; Jakobsen G; Brock B; Chandramouli V; Rungby J; Landau BR; Schmitz O
    Diabetes; 2004 May; 53(5):1187-94. PubMed ID: 15111485
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Retrospective review of postoperative glycemic control in patients after distal pancreatectomy.
    Liu A; Carmichael KA; Schallom ME; Klinkenberg WD
    Int J Surg; 2017 May; 41():86-90. PubMed ID: 28347869
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of glucagon-like peptide 1(7-36) amide on glucose effectiveness and insulin action in people with type 2 diabetes.
    Vella A; Shah P; Basu R; Basu A; Holst JJ; Rizza RA
    Diabetes; 2000 Apr; 49(4):611-7. PubMed ID: 10871199
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of glucagon response on early postprandial glucose excursions irrespective of residual β-cell function in type 1 diabetes: A cross-sectional study using a mixed meal tolerance test.
    Ito A; Horie I; Miwa M; Sako A; Niri T; Nakashima Y; Shigeno R; Haraguchi A; Natsuda S; Akazawa S; Kamada A; Kawakami A; Abiru N
    J Diabetes Investig; 2021 Aug; 12(8):1367-1376. PubMed ID: 33369175
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of subcutaneous, low-dose glucagon on insulin-induced mild hypoglycaemia in patients with insulin pump treated type 1 diabetes.
    Ranjan A; Schmidt S; Madsbad S; Holst JJ; Nørgaard K
    Diabetes Obes Metab; 2016 Apr; 18(4):410-8. PubMed ID: 26743775
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Pathophysiology in diabetes after major resection of the pancreas, with special reference to insulin metabolism and glucagon secretion (author's transl)].
    Iwasaki M
    Nihon Naibunpi Gakkai Zasshi; 1982 Mar; 58(3):248-58. PubMed ID: 7047223
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.